Start Date: 08/06/2017

End Date: 08/06/2017

Cost: 210

Venue: Central London


Westminster Forum Projects

Contact Details:

The future of biosimilars in the UK: regulation, access and medicines optimisation

Thursday, 8th June 2017

Central London


Guest of Honour


Dr Christian Schneider, Director, National Institute for Biological Standards and Control, MHRA


This seminar will provide the opportunity to discuss the future of biosimilar medicines in the UK.

Delegates will assess the next steps for regulation and pharmacovigilance, the impact of increased competition between originator and biosimilar manufacturers and the challenges for embedding use in service delivery following the publication of NHS England’s ‘What is a biosimilar medicine?’ guide.

Sessions will also focus on the implications of the UK vote to leave the European Union on access to biosimilars, key issues for clinicians around switching from originator to biosimilar - and the next steps for patient engagement, education and involvement.